对患有葡萄糖皮质醇诱导骨质疏松症的儿科患者的方法
Leanne M Ward1, Sarah A Bakhamis1, Khaldoun Koujok2
1Department of Pediatrics, Faculty of Medicine, University of Ottawa and Division of Endocrinology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada, K1H 8L1.
The Journal of clinical endocrinology and metabolism
|August 10, 2024
概括
葡萄糖皮质激素 (GC) 治疗可以导致儿科骨质疏松症 (pGIO). 早期的骨折识别和干预,特别是脊椎骨折,对于管理PGIO和预防进一步的骨损伤至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 儿科风湿病学 儿科风湿病学
- 儿科整形外科 儿科整形外科
背景情况:
- 葡萄糖皮质激素 (GC) 治疗对于儿童的疾病至关重要,但会导致显著的骨发病率.
- 儿科GC诱导的骨质疏松症 (pGIO) 需要谨慎管理,以减轻长期的骨健康问题.
研究的目的:
- 概述儿童GC诱导骨质疏松症 (pGIO) 的基本临床生物原则.
- 强调关键概念,包括骨折表型,监测,骨密度评估和脊椎重塑的治疗影响.
主要方法:
- 临床病例的审查,说明pGIO的核心管理原则.
- 专注于纵向脊椎骨折评估和基于风险的监测策略.
主要成果:
- 早期识别骨折,包括脊椎骨折,对于危险儿童及时干预至关重要.
- 骨矿物质密度在pGIO评估中发挥作用,脊椎体重塑影响治疗决策.
结论:
- 有效的PGIO管理依赖于早期骨折检测和干预,特别是当自发恢复有限时.
- 虽然双酸盐是第一线药物,但未来的研究需要探索用于预防高风险儿科人群骨折的合成代谢剂.
相关概念视频
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Hypoglycemia and Glucagon
224
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
224
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Fractures: Bone Repair
3.1K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.1K
Insulin: Dosing Regimen and Adverse Effects
162
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
162


